FDA Presses Pause on Trial for OTC Version of Anti-impotence Drug Cialis

The US health regulator has put on hold a trial designed to evaluate switching the prescription-only erectile dysfunction drug Cialis to an over-the-counter treatment, French drugmaker Sanofi said on Monday.
Reuters Health Information

source https://www.medscape.com/viewarticle/974787?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

DC’s Harllee Harper Is Using Public Health Tools to Prevent Gun Violence. Will It Work?